Wird geladen...
Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
Over the last decade, several rhythm‐versus rate‐control trails in patients with atrial fibrillation (AF) have failed to demonstrate benefit of the rhythm control strategy with respect to mortality and morbidity. This had let to the guideline recommendation that antiarrhythmic drug therapy should be...
Gespeichert in:
| Veröffentlicht in: | Clin Cardiol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley Periodicals, Inc.
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652313/ https://ncbi.nlm.nih.gov/pubmed/22246949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20959 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|